Skip to Content
Behavioral SciencesBehavioral Sciences
  • Feature Paper
  • Conference Report
  • Open Access

24 January 2018

7 Pages

Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase

Cuban Council of Veterinary Sciences, Paseo 604 Vedado CP, La Habana 10400, Cuba

Abstract

This manuscript comments on guidelines related to requirements for clinical trials for new drugs and the importance of considering regulatory criteria in the planning phase, in order to enhance the utility of data generated in basic research. Suggestions are made for optimizing regulatory management to improve the likelihood of acceptance of pre-clinical data prior to Clinical Phase I trials (early clinical trials).

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.